Cargando…
Differentiation Syndrome, a Side Effect From the Therapy of Acute Promyelocytic Leukemia
Differentiation Syndrome is a complication of all-trans retinoic acid (ATRA) therapy in patients with acute promyelocytic leukemia (APML). It appears clinically as acute end-organ damage with peripheral edema, hypotension, acute renal failure, and interstitial pulmonary infiltrates. When symptoms de...
Autores principales: | Reyhanoglu, Gizem, Hughes, Benjamin, King, Katherine E, Cambridge, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802406/ https://www.ncbi.nlm.nih.gov/pubmed/33447473 http://dx.doi.org/10.7759/cureus.12042 |
Ejemplares similares
-
Therapy-Related Acute Promyelocytic Leukemia Developed During Pembrolizumab Therapy
por: Ober, Cecily E, et al.
Publicado: (2023) -
Rectal Cancer Complicated by Acute Promyelocytic Leukemia
por: Alkhayyat, Shadi
Publicado: (2020) -
Promyelocytic Blast Crisis of Chronic Myeloid Leukemia in a Patient Undergoing Therapy with a Tyrosine Kinase Inhibitor
por: Parsi, Meghana, et al.
Publicado: (2020) -
Differentiation syndrome in patients with acute promyelocytic leukemia
por: Elamin, Nusiba H., et al.
Publicado: (2023) -
Bronchoalveolar lavage fluid review in acute promyelocytic leukemia differentiation syndrome
por: Seifert, Robert P., et al.
Publicado: (2021)